TABLE 1.
| Compound | Trade name | CPZ equiv |
Dose (mg/d) |
Maintenance (mg/d) |
|---|---|---|---|---|
| First generation (FGA) | ||||
| Fluphenazine | Prolixin | 2 | 6–20 | 6–12 |
| Trifluperazine | Stelazine | 15–50 | 15–30 | |
| Perphenazine | Trilafon | 10 | 30–100 | 30–60 |
| Mesoridazine | Serentil | 50 | 150–400 | 150–300 |
| Chlorpromazine | Thorazine | 100 | 300–1000 | 300–600 |
| Thioridazine | Navane | 100 | 300–800 | 300–600 |
| Haloperidol | Haldol | 2 | 6–20 | 6–12 |
| Thiothixene | Navane | 5 | 15–50 | 15–30 |
| Molindone | Moban | 10 | 30–100 | 30–60 |
| Loxapine | Loxitane | 10 | 30–100 | 30–60 |
| Second generation (SGA) | ||||
| Clozapine | Clozaril | 150–600 | 150–600 | |
| Risperidone | Risperidal | 2–8 | 2–8 | |
| Paliperidone | Invega | 3–15 | 3–15 | |
| Olanzapine | Zyprexa | 10–20 | 10–20 | |
| Quetiapine | Seroquel | 300–750 | 300–750 | |
| Ziprasidone | Geodon | 120–160 | 80–160 | |
| Aripiprazole | Abilify | 10–30 | 10–30 | |
| Asenapine | Sepharis | 10–20 | 10–20 | |
| Iloperidone | Fanapt | 12–24 | 12–24 | |
| Lurasidone | Latuda | 40–160 | 40–160 | |
| Cariprazine | 1.5–12 | 1.5–9 | ||
| Long acting injectables (LAI) | ||||
| Fluphenazine decanoate | Modecate | 12.5–25 | 12.5–100 (/2 wks) | |
| Haloperidol decanoate | Haldol | 100 | 100–450 (/4 wks) | |
| Risperidone microspheres | Risperidol consta | 251 | 25–50 (/2 wks) | |
| Paliperidone palmitate | Invega Sustenna | 234 day 1; 156, day 7 | 39–234 (/4 wks) | |
| Olanzapine pamoate | Zyprexa Relprevv | 300 | 300 (/2 wks) | |
| Aripiprazole suspension | Abilify Maintena | 4002 | 300–400 (monthly) |
supplemental oral medication needed × 3 wks;
supplemental oral medication needed × 2 wks